Lexaria Bioscience Corp. (LEXX) — 分析师展望 / 分析师共识目标价为. 基于 2 位分析师评级, 共识为 看涨 — 2 买入.
分析师共识目标价为 $1.50, 上涨空间为 47.1% 相对于当前价格 $1.02.
分析师预估 每股收益(EPS)为 $-0.44 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.47 vs 预期 $-0.44 (不及预期 -6.8%). 2025: 实际 $-0.66 vs 预期 $-0.68 (超预期 +2.9%). 分析师准确度: 95%.
LEXX 股票 — 12个月价格预测
$1.50
▲ +47.06% 上涨空间
平均目标价
Based on 2 Wall Street analysts offering 12-month price targets for Lexaria Bioscience Corp., the price target is $1.50.
平均目标价相对最新价格 $1.02 变动 +47.06%。
LEXX 分析师评级
Buy
基于过去3个月内 2 位分析师对 Lexaria Bioscience Corp. 的评级
EPS 预测 — LEXX
95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.47
vs Est –$0.44
▼ 6.4% off
2025
Actual –$0.66
vs Est –$0.68
▲ 3.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — LEXX
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.001B
▼ 7.7% off
2025
Actual $0.001B
vs Est $0.001B
▲ 5.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
